Delivery Order SPE2DB22D2009-SPE2DB25FL7XX
Award Date
2/18/25
Potential Completion Date
2/19/25
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,226.11 firm fixed-price contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a medical product, with a period of performance through January 9, 2025. The award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
The U.S. Defense Logistics Agency (DLA) awarded a $9,126.26 firm fixed price delivery order contract to AmerisourceBergen Drug Corp for the supply of OPZELURA 1.5% Cream in 60 gram units. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to military treatment facilities worldwide. The contract does not have a set-aside designation and is scheduled...
This is a $73,666.92 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream 60GM, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025 and is a firm fixed-price arrangement. There is no set-aside designation for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $17,293.59, is for the delivery of OPZELURA 1.5% Cream in 60 gram packaging. The order is a firm fixed-price contract with a completion date of July 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,665.65, is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product, to support military healthcare programs. The contract is a firm fixed-price, delivery order type, with a period of performance through January 7, 2025. No set-aside designation is mentioned. AmerisourceBergen...
This is a $3,612.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of OPZELURA 1.5% cream in 60g quantities. The contract has an ultimate completion date of September 11, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,502.37, is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a period of performance through December 23, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award, valued at $8,025.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a completion date of February 27, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract has a ceiling value of $12,900.63 and an ultimate completion date of December 3, 2024. This is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is not designated as a set-aside....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,825.57, is for the provision of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...